Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 149 The United Laboratories International Holdings Limited Annual Report 2021 41. RECONCILIATION OF LIABILITIES ARISING FROM FINANCING ACTIVITIES The table below details changes in the Group’s liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flows were, or future cash flows will be, classified in the Group’s consolidated statement of cash flows as cash flows from financing activities. Treasury stock Borrowings Convertible bonds Lease liabilities Derivative financial instrument Dividend payable Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 (Note 28) (Note 29) (Note 27) (Note 15) At 1 January 2020 – 3,987,989 1,008,433 1,763 – – 4,998,185 Financing cash flows – (1,765,948) (13,226) (1,721) – (128,140) (1,909,035) Derecognition of bills receivables – (61,793) – – – – (61,793) Conversion of convertible bond – – (1,361,364) – – – (1,361,364) Fair value change – – 314,614 – 4,573 – 319,187 Finance costs – 145,953 42,981 80 – – 189,014 Dividend declared – – – – – 128,140 128,140 Exchange (gain) loss – (96,550) 8,562 – – – (87,988) Non-cash changes – New Leases entered – – – 1,800 – – 1,800 – Lease modification – – – (236) – – (236) At 31 December 2020 – 2,209,651 – 1,686 4,573 – 2,215,910 Financing cash flows (41,140) (364,556) – (3,742) 9,359 (220,847) (620,926) Fair value change – – – – (8,120) – (8,120) Derecognition of bills receivables – (26,493) – – – – (26,493) Recognition of bills receivables – 18,353 – – – – 18,353 Finance costs – 63,532 – 697 – – 64,229 Dividend declared – – – – – 220,847 220,847 Exchange gain – (69,369) – – – – (69,369) Non-cash changes – New Leases entered – – – 12,355 – – 12,355 – Cancellation of treasury stock 23,325 – – – – – 23,325 At 31 December 2021 (17,815) 1,831,118 – 10,996 5,812 – 1,830,111